These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ig apheresis for the treatment of severe DCM patients. Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167 [TBL] [Abstract][Full Text] [Related]
9. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Müller J; Wallukat G; Dandel M; Bieda H; Brandes K; Spiegelsberger S; Nissen E; Kunze R; Hetzer R Circulation; 2000 Feb; 101(4):385-91. PubMed ID: 10653829 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465 [TBL] [Abstract][Full Text] [Related]
12. [The role of anti-beta1-adrenergic receptor autoantibodies in development of heart failure]. Tonevitskiĭ AG; Tabak'an EA Ross Fiziol Zh Im I M Sechenova; 2006 Mar; 92(3):330-41. PubMed ID: 16739643 [TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension. Dandel M; Wallukat G; Englert A; Hetzer R Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166 [TBL] [Abstract][Full Text] [Related]
14. Beta Camino M; Morales MD Front Biosci (Elite Ed); 2019 Jan; 11(1):102-108. PubMed ID: 30468641 [TBL] [Abstract][Full Text] [Related]
15. Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA. Holthoff HP; Zeibig S; Jahns-Boivin V; Bauer J; Lohse MJ; Kääb S; Clauss S; Jahns R; Schlipp A; Münch G; Ungerer M Circ Res; 2012 Aug; 111(6):675-84. PubMed ID: 22811559 [TBL] [Abstract][Full Text] [Related]
17. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy. Dandel M; Wallukat G; Potapov E; Hetzer R Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755 [TBL] [Abstract][Full Text] [Related]
18. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841 [TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption as treatment option in dilated cardiomyopathy. Felix SB; Staudt A Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476 [TBL] [Abstract][Full Text] [Related]
20. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy. Bulut D; Creutzenberg G; Mügge A Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]